Skip to content
Case report Open access

Case Report: a hypermetabolic mediastinal mass (SUVmax 16.7) mimicking malignancy with spontaneous resolution: an inflammatory myofibroblastic proliferation and diagnostic pitfall

Aug 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 16 references
Medicine

TL;DR

An inflammatory myofibroblastic proliferation in the mediastinum may exhibit extreme FDG avidity, indistinguishable from malignancy on imaging, while acknowledging that complete distinction from an ALK-negative inflammatory myofibroblastic tumor cannot be made with absolute certainty on limited core-biopsy material alone.

Abstract

Background Hypermetabolic mediastinal masses on 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) are presumed malignant until proven otherwise. However, benign inflammatory and organizing processes may exhibit equally intense metabolic activity, posing a diagnostic challenge—particularly when the lesion abuts major vascular structures and limits safe tissue sampling. Case summary A 55-year-old male smoker presented with cough, right-sided chest pain, low-grade fever, and mild dysphagia. Contrast-enhanced CT identified an ill-defined mass in the retrotracheal region of the superior mediastinum (within the tracheoesophageal groove), measuring 1.8×2.6×3.2 cm, with poorly defined margins against the esophagus and heterogeneous enhancement (precontrast attenuation 17–41 Hounsfield units (HU)). [18F]FDG PET/CT demonstrated markedly elevated [18F]FDG uptake (maximum standardized uptake value [SUVmax], 16.7), raising strong suspicion for malignancy. Serum tumor markers, procalcitonin, interleukin-6, and total immunoglobulin E (IgE) were within normal limits; sputum acid-fast, fungal, and bacterial cultures were negative, as were Epstein–Barr virus, cytomegalovirus, and a respiratory virus panel. Endobronchial ultrasound (EBUS)-guided aspiration did not yield a diagnostic specimen. CT-guided core needle biopsy was safely performed despite proximity to the superior vena cava and aortic arch, without complications. Histopathology revealed fibrocollagenous tissue with lymphoplasmacytic infiltration and foamy histiocytes, without malignant cells. Immunohistochemistry showed anaplastic lymphoma kinase (ALK) negativity, smooth muscle actin (SMA) positivity, and immunoglobulin G4 (IgG4) sparse focal weak positivity (below the threshold for IgG4-related disease), and a Ki-67 index of approximately 30% that labeled predominantly inflammatory cells rather than spindle cells, consistent with an inflammatory myofibroblastic proliferation. No antineoplastic, further targeted antimicrobial, or immunosuppressive therapy was administered. Follow-up CT at approximately 2.5 months demonstrated complete spontaneous resolution of the mass. A repeat chest CT in July 2026, approximately 2 months after the scan that first documented complete resolution, continued to show no residual or recurrent mediastinal lesion. Taken together, the findings favored an inflammatory myofibroblastic proliferation with an organizing, self-limiting course, while acknowledging that complete distinction from an ALK-negative inflammatory myofibroblastic tumor cannot be made with absolute certainty on limited core-biopsy material alone. Conclusion An inflammatory myofibroblastic proliferation in the mediastinum may exhibit extreme FDG avidity (SUVmax 16.7) indistinguishable from malignancy on imaging. A Ki-67 index of ~30% that labels predominantly inflammatory cells supports reactive proliferative activity as a histological correlate of the elevated metabolic signal, whereas complete spontaneous resolution sustained on repeat CT supports a self-limiting inflammatory course. When tissue sampling and subsequent clinical evolution make malignancy and active infection less likely, short-interval imaging surveillance may be an appropriate strategy in carefully selected patients.

Read PDF

Similar papers

Aug 2026

Diagnostic Pitfall of 18F-FDG PET/CT: Unifocal Nonbacterial Osteomyelitis Mimicking Bone Metastasis.

Chronic nonbacterial osteomyelitis (CNO) is a rare inflammatory bone disorder of unclear etiology that may present with unifocal or multifocal lesions. Because it can mimic malignancy on imaging, clinicoradiologic correlation and a multidisciplinary approach are essential. We report unifocal inflammatory osteitis compatible with CNO involving the sternum in a 56-y-old woman with a history of ductal carcinoma in situ. During surveillance, bone scintigraphy showed focal 99mTc-methylene diphosphonate uptake and 18F-FDG PET/CT revealed a solitary 18F-FDG-avid sternal lesion. MRI findings were suggestive of osteomyelitis. Biopsy excluded malignancy, supporting a diagnosis of CNO. Follow-up MRI demonstrated regression. This case underscores that a solitary 18F-FDG-avid sternal lesion does not necessarily represent metastatic disease, and histopathologic confirmation may prevent unnecessary treatment escalation.

M. Daşar, A. Akbulut, K. Demirel et al. · 0 citations
Case report 2026

Multisystem FDG-avid lesions mimicking malignancy in a teenager with hyper-IgE syndrome: A case study with literature review

Hyper-IgE Syndrome (HIES) is a rare immunodeficiency predisposing patients to infections, inflammation, and occasional neoplasia. We report a 17-year-old boy with HIES who presented with severe right thigh pain. FDG-PET/CT demonstrated a right adrenal mass (SUVmax=5.4), multiple pulmonary nodules, and a lytic-sclerotic femoral lesion (SUVmax=4.6), initially suggesting disseminated malignancy. Biopsy confirmed acute osteomyelitis and a benign spindle cell tumor of the adrenal gland. Two months later, persistent fever and elevated ESR prompted re-evaluation, revealing intense FDG uptake in the thoracic aorta (SUVmax=20.5) consistent with large vessel vasculitis, later confirmed by angiography. The combination of infection, benign tumor, and vasculitis illustrates the broad FDG uptake spectrum in HIES and the risk of misdiagnosis as malignancy. Integration of clinical, imaging, and histopathologic data was critical for accurate diagnosis. This case highlights FDG-PET/CT’s value in detecting inflammatory vascular disease and monitoring therapy, while reinforcing the importance of biopsy for definitive diagnosis. In immunodeficient patients, a multimodal diagnostic approach is essential to distinguish between malignant and benign FDG-avid lesions.

Fatemeh Saboktakin, Saeed Farzanefar, Nasim Vahidfar et al. · 0 citations
Case report Jul 2026

First Reported Pediatric Bladder Inflammatory Myofibroblastic Tumor (IMT) Evaluated and Staged with VI-RADS: CT and MR Findings.

INTRODUCTION Inflammatory Myofibroblastic Tumor (IMT) is a rare intermediate softtissue neoplasm that can arise in virtually any organ, including the urinary bladder. Accurate diagnosis is challenging but crucial, as conservative treatment approaches may be feasible. CASE PRESENTATION An 11-year-old boy presented with dysuria and microscopic hematuria. Ultrasound and Computed Tomography (CT) revealed a bladder mass associated with right-sided ureterohydronephrosis. Multiparametric Magnetic Resonance Imaging (mpMRI), performed for local staging using the Vesical Imaging Reporting and Data System (VI-RADS), demonstrated moderate diffusion restriction of the lesion on Diffusion-Weighted Imaging (DWI). However, the extent of bladder wall invasion was not clearly defined. Dynamic Contrast-Enhanced (DCE) T1-weighted SPIR sequences showed disruption of the hypointense muscularis propria with early extension into the ureteral wall at the intramural segment. Histopathological examination of biopsy specimens confirmed an inflammatory myofibroblastic tumor with muscular layer involvement. The patient received five months of chemotherapy with methotrexate and vinblastine, followed by partial cystectomy and ureteral reimplantation. Three years after treatment, follow-up MRI demonstrated no evidence of locoregional recurrence, indicating a complete response. CONCLUSION In this rare case of pediatric bladder IMT, MRI proved valuable for assessing locoregional tumor extent, guiding surgical planning, and evaluating treatment response. In particular, the case highlights the potential role of VI-RADS-based assessment in the staging and management of bladder IMT.

P. P. Arcuri, Simonetta Antonelli, E. Galea et al. · 0 citations
Open access Jul 2026

18 F-FDG and 68 Ga-FAPI PET/CT Imaging in a Patient with High-Grade Meningioma: A Case Report

Abstract High-grade meningiomas exhibit aggressive biological behavior and may benefit from functional imaging for further characterization. We report a 50-year-old female presenting with a 1-year history of intermittent right-sided headache and recurrent seizures. Contrast-enhanced magnetic resonance imaging demonstrated a well-defined extra-axial mass arising from the right sphenoid wing dura mater, accompanied by hyperostosis, dural tail sign, and vasogenic edema. 18 F-FDG and 68 Ga-FAPI PET/CT ( 68 Ga-fibroblast activation protein inhibitor positron emission tomography/computed tomography) were performed 1 week apart. FDG PET/CT demonstrated a tumor SUVmax of 7.08, comparable to the contralateral substantia nigra (SUVmax 7.27), resulting in limited lesion-to-background contrast (T/N ratio 0.97). In contrast, FAPI PET/CT showed tumor SUVmax of 3.02, with the aorta used as the background reference (SUVmean 1.76), yielding a tumor-to-background ratio of 1.71 and improved visual delineation due to minimal physiological brain uptake. Histopathology confirmed atypical meningioma (World Health Organization grade II). Although FAPI demonstrated higher tumor-to-background contrast than FDG, uptake remained relatively mild, suggesting predominant stromal mesenchymal involvement. Further comparative studies with established modalities such as somatostatin receptor PET are warranted.

Arif Satria Putra Pratama, H. Budiawan, T. Nugrahadi et al. · 0 citations
Open access Aug 2026

The Role of F-18 FDG PET/CT in the Evaluation of Solitary Pulmonary Nodules.

Objective Fluorine-18 fluorodeoxyglucose positronemissiontomography/computedtomography (F-18 FDG PET/CT) is commonly used in the evaluation of solitary pulmonary nodules (SPNs). This study aimed to investigate the predictive value of maximum standardized uptake value (SUVmax) and its ratios to liver and mediastinal blood pool SUVmax values for malignancy in SPNs, using histopathological findings as the reference standard. Methods The study included 130 patients who underwent F-18 FDG PET/CT and had either histopathological confirmation or at least two years of radiological follow-up. Demographic data (age and sex), nodule size, location, contour characteristics, nodule SUVmax, nodule-to-liver SUVmax ratio (NLR), and nodule-to-mediastinal blood pool SUVmax ratio (NBR) were recorded. Nodules were classified as benign or malignant based on histopathological results. Results Among the 83 patients with histopathological diagnosis, 54% (n = 44) had malignant lesions and 46% (n = 39) had benign lesions. The mean size of malignant nodules was approximately 20 mm. Receiver operating characteristic (ROC) analysis demonstrated that an SUVmax cutoff value of 4.02 provided the highest diagnostic accuracy for predicting malignancy. Both NLR and NBR showed significant diagnostic value in malignancy prediction. These parameters demonstrated high sensitivity (84-91%) and negative predictive value (76-84%), indicating their usefulness in excluding benign nodules. Conclusion The F-18 FDG PET/CT is a valuable imaging modality in the evaluation of solitary pulmonary nodules. In addition to SUVmax, the use of NLR and NBR may improve diagnostic accuracy and contribute to clinical decision-making.

Erdal Çetinkaya, Fatih Guzel, S.A. Tuzcu et al. · 0 citations